Literature DB >> 12210936

Simultaneous perfusion and BOLD imaging using reverse spiral scanning at 3T: characterization of functional contrast and susceptibility artifacts.

Yihong Yang1, Hong Gu, Wang Zhan, Su Xu, David A Silbersweig, Emily Stern.   

Abstract

Reverse spiral scanning with arterial spin-labeling was developed at 3T to simultaneously detect perfusion and BOLD signals in the brain by subtracting or adding the control and labeled images, respectively, in the same dataset. BOLD contrast was improved with the longer effective echo time achieved in the reverse spiral scan compared to conventional forward spiral scans. Susceptibility artifacts near air-tissue interfaces in the brain were substantially reduced in the reverse spiral images due to their early data acquisition time and, hence, less signal attenuation. Brain activation experiments with the reverse spiral scan were performed on normal subjects and were compared to forward spiral imaging in the same subjects. The experiments demonstrated that reverse spiral imaging was able to detect perfusion and BOLD signals simultaneously and reliably, even in the brain regions with severe susceptibility-induced local gradients, while forward spiral scans were either not optimal for detecting the two functional signals at the same time or were vulnerable to susceptibility artifacts. Copyright 2002 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2002        PMID: 12210936     DOI: 10.1002/mrm.10196

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  26 in total

1.  Updating beliefs for a decision: neural correlates of uncertainty and underconfidence.

Authors:  Emily R Stern; Richard Gonzalez; Robert C Welsh; Stephan F Taylor
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Simultaneous acquisition of gradient echo/spin echo BOLD and perfusion with a separate labeling coil.

Authors:  C B Glielmi; Q Xu; R C Craddock; X Hu
Journal:  Magn Reson Med       Date:  2010-12       Impact factor: 4.668

3.  Comparison of continuous overt speech fMRI using BOLD and arterial spin labeling.

Authors:  Stefan Kemeny; Frank Q Ye; Rasmus Birn; Allen R Braun
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

4.  The impact of susceptibility gradients on cartesian and spiral EPI for BOLD fMRI.

Authors:  Ryan Sangill; Mikkel Wallentin; Leif Østergaard; Peter Vestergaard-Poulsen
Journal:  MAGMA       Date:  2006-07-06       Impact factor: 2.310

5.  Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T.

Authors:  Lu-Ping Li; Anthony T Vu; Belinda S Y Li; Eugene Dunkle; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2004-11       Impact factor: 4.813

6.  Medial frontal cortex and anterior insula are less sensitive to outcome predictability when monetary stakes are higher.

Authors:  Emily R Stern; Richard Gonzalez; Robert C Welsh; Stephan F Taylor
Journal:  Soc Cogn Affect Neurosci       Date:  2013-09-26       Impact factor: 3.436

7.  Comparison of image quality in magnetic resonance imaging of the knee at 1.5 and 3.0 Tesla using 32-channel receiver coils.

Authors:  F Schoth; N Kraemer; T Niendorf; C Hohl; R W Gunther; G A Krombach
Journal:  Eur Radiol       Date:  2008-05-08       Impact factor: 5.315

8.  Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness.

Authors:  Keith D Sudheimer; James L Abelson; Stephan F Taylor; Brian Martis; Robert C Welsh; Christine Warner; Mira Samet; Andrea Manduzzi; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2012-12-03       Impact factor: 7.853

9.  Topographic analysis of individual activation patterns in medial frontal cortex in schizophrenia.

Authors:  Emily R Stern; Robert C Welsh; Kate D Fitzgerald; Stephan F Taylor
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

Review 10.  Blood oxygen level-dependent MR imaging of the kidneys.

Authors:  Lu-Ping Li; Sarah Halter; Pottumarthi V Prasad
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.